CN1253171C - Chinese medicine preparation for treating blood viscosity symdrome and its preparing method - Google Patents
Chinese medicine preparation for treating blood viscosity symdrome and its preparing method Download PDFInfo
- Publication number
- CN1253171C CN1253171C CN 03136116 CN03136116A CN1253171C CN 1253171 C CN1253171 C CN 1253171C CN 03136116 CN03136116 CN 03136116 CN 03136116 A CN03136116 A CN 03136116A CN 1253171 C CN1253171 C CN 1253171C
- Authority
- CN
- China
- Prior art keywords
- preparation
- blood viscosity
- treating blood
- blood
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese materia medica preparation for treating blood viscosity syndromes and a preparation method thereof. The Chinese materia medica preparation for treating blood viscosity syndromes is prepared under the synergy of traditional Chinese medicines according to different characteristics, wherein the traditional Chinese medicines comprise kudzuvine root, ginkgo leaf, Chinese angelica, white peony root, kendir, hebar erigerontis and semen cassiae, the traditional Chinese medicines are prepared according to the weight distribution ratio, the traditional Chinese medicines are pulverized into powder of 180 meshes, and then, the powder is sterilized and encapsulated to obtain the Chinese materia medica preparation for treating blood viscosity syndromes. Clinical therapy of 128 cases shows that the present invention has the advantages that the effective rate is 100%, the cure rate is 99.2%, and the Chinese materia medica preparation for treating blood viscosity syndromes has reasonable and scientific synergy, simple production process, low price, convenient administration, obvious effect and popularization.
Description
Affiliated technical field
The present invention relates to a kind of Chinese medicine preparation for the treatment of Blood Ropy disease and preparation method thereof, specifically a kind of Chinese medicinal capsule and this capsular preparation method for the treatment of Blood Ropy disease belongs to Chinese patent drug technique field.
Background technology
Blood Ropy disease is the known nominal of people " blood is a thick " disease, doctor trained in Western medicine is called " hyperlipemia ", this disease is touching not to heal, and complication is a lot, because blood viscosity is too high, blood circulation is not smooth, make coronary insufficiency, cause coronary atherosclerosis, myocardial infarction can take place in severe patient, perhaps cerebrovascular sclerosis forms diseases such as cerebral thrombosis, cerebral infarction.At present, the medicine for the treatment of this disease is a lot, and as " high fat sheet ", " Xuezhikang " etc., but general curative effect is slow, and effect is not lasting, the price height, and cure rate is low.
Summary of the invention
In order to overcome above-mentioned deficiency, the invention provides a kind of Chinese medicinal capsule for the treatment of Blood Ropy disease, this Chinese medicinal capsule can reduce serum cholesterol and triglyceride, improves cholesterol and phospholipid ratio, blood pressure lowering, heart tonifying, strengthen the cardiovascular and cerebrovascular vessel blood supply, alleviate the heart and brain arteriospasm, vessel softening, reduce platelet aggregation, reduce the oxygen consumption of heart and brain cell; The present invention is by the theory of Chinese medical science composition of prescription, make its performance blood fat reducing, blood pressure lowering, enhancing cardiac and cerebral blood-supply, alleviate arteriosclerosis, diseases such as prevention ischemic angiocardiopathy and cerebrovascular, it is evident in efficacy, effect is lasting, and is cheap, taking convenience, the cure rate height, be a kind of ideal Chinese medicinal capsule, prove, welcome by the patient through clinical practice.
Medicine of the present invention is made up of following component: (consumption is a weight portion)
Radix Puerariae 10-20 Folium Ginkgo 10-20 Radix Angelicae Sinensis 3-12
Radix Paeoniae Alba 3-10 Herba Apocyni veneti 10-20 Herba Erigerontis 2-6
Semen Cassiae 40-50
Formula optimization weight (part) ratio range of preparation medicine of the present invention is:
Radix Puerariae 11-21 Folium Ginkgo 11-20 Radix Angelicae Sinensis 4-15
Radix Paeoniae Alba 4-14 Herba Apocyni veneti 10-21 Herba Erigerontis 3-7
Semen Cassiae 45-55
The optimum weight of medicine of the present invention (part) proportioning is:
Radix Puerariae 10.5 Folium Ginkgos 10.5 Radix Angelicae Sinensis 3.5
The Radix Paeoniae Alba 3.5 Herba Apocyni venetis 10.5 Herba Erigerontiss 2.5
Semen Cassiae 47
Above-mentioned each component is made medicine production method of the present invention is:
1, selected above-mentioned each component medical material, carry out selected, clean, natural drying takes by weighing the medical material of each component weight by optimum weight (part) proportioning, carries out mixed powder and is broken to 180 order fine powders.
2, sterilize after the fine powder that crushes is uniformly mixed, the sterilization back incapsulates by the weight of every granule 0.5g.
3, this medicament capsule of making pack into the bottle in the sealing stand-by.
Characteristics of the present invention are, each Chinese medicine reasonable mixture ratio of distinguishing the flavor of is joined according to the characteristic of each medicine and to be controlled:
Radix Puerariae: expand strong coronary vasodilator and cerebrovascular, blood flow is increased, can expand external perihaemal canal, make Peripheral resistance decline and tangible hypotensive effect is arranged;
Herba Apocyni veneti: toxic hair K mainly acts on blood pressure lowering, diuresis;
Folium Ginkgo: blood flow increasing, reduce serum cholesterol, improve cholesterol and phospholipid ratio, its effect is a treatment coronary heart disease, angina pectoris, hypertension, hypercholesterolemia disease;
Semen Cassiae: contain emodin, chrysophanic acid, Radix Et Rhizoma Rhei alkali, blood pressure lowering, blood fat reducing;
The Radix Paeoniae Alba: anti-frightened calm, improve cerebral blood supply, expansion of cerebral vascular, the blood perfusion of increase brain improves the brain cell metabolism, suppresses sick and decreases, and increases mediation function, the clinical cerebral arteriosclerosis that is used for, cerebral vasospasm, Ischemic Stroke;
Radix Angelicae Sinensis: contain Artemisia benzene lactone, the acid of VB12 a small bundle of straw, etc. for silkworms to spin cocoons on, folic acid, biotin vitamin E, main effect is a coronary artery dilator, increases blood flow coronarius, reduces the oxygen consumption of heart and brain cell, adjusts heart rate, reduces platelet aggregation, antithrombotic forms, blood fat reducing;
Herba Erigerontis: invigorate blood circulation, blood stasis dispelling thrombolytic collaterals-activating.
Instructions of taking of the present invention: 4 capsules/time, day clothes 3 times, early, eliminating cold for resuscitation water is taken before noon, supper.One month is a course of treatment, waits to chemically examine backsight TC, TG value, changes to take metering and number of times.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, each component of the present invention meets the pharmaceutical control law regulation, utilizes the comprehensive function treatment Blood Ropy disease of the Chinese medicine of respectively distinguishing the flavor of,, side effect nontoxic to human body.
2, the present invention need not decoct, and taking convenience meets national medical and health law regulation.
3, therapeutic effect of the present invention is obvious, and can alleviate or remove other complication significantly, strengthens body immunity.
4, cost is low, and general patient can both obey and affords to use, and alleviates medical expense, can effect a radical cure and not rebound.
For showing the therapeutic effect of medicine of the present invention to Blood Ropy disease, through the clinical observation of 128 case systems, its therapeutic effect is:
Change before and after serum total cholesterol, the triglyceride treatment
As seen from the above table: total effective rate is: 100%
Cure rate is: 99.2%
The specific embodiment
Take by weighing the raw material (kilogram) of selected, cleaning, natural drying by following proportioning:
Radix Puerariae 5.25 Folium Ginkgos 5.25 Radix Angelicae Sinensis 1.75
The Radix Paeoniae Alba 1.75 Herba Apocyni venetis 5.25 Herba Erigerontiss 1.25
Semen Cassiae 23.5
It is 180 orders that above-mentioned various Chinese medicines are pulverized, and fully mixes stirring, sterilization then, by each capsule 0.5g that packs into, makes capsule, and sealing in the bottle of packing into becomes the capsule preparations that the present invention treats hyperlipidemia.
Claims (3)
1, a kind of Chinese medicine preparation for the treatment of Blood Ropy disease, it is characterized in that: it is made up of following components by part by weight:
Radix Puerariae 10-20 Folium Ginkgo 10-20 Radix Angelicae Sinensis 3-12
Radix Paeoniae Alba 3-10 Herba Apocyni veneti 10-20 Herba Erigerontis 2-6
Semen Cassiae 40-50
2, a kind of preparation method for the treatment of the Chinese medicine preparation of Blood Ropy disease according to claim 1, it is characterized in that: the weight proportion of each component is:
Radix Puerariae 10.5 Folium Ginkgos 10.5 Radix Angelicae Sinensis 3.5
The Radix Paeoniae Alba 3.5 Herba Apocyni venetis 10.5 Herba Erigerontiss 2.5
Semen Cassiae 47
3, a kind of preparation method for the treatment of the Chinese medicine preparation of Blood Ropy disease according to claim 1, it is characterized in that: this preparation method is with the weight proportion of various Chinese medicines by selected, cleaning, natural drying, pulverizing is 180 purpose powder, sterilization then, by every capsules 0.5g that packs into, make capsule, sealing in the bottle of packing into.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03136116 CN1253171C (en) | 2003-05-15 | 2003-05-15 | Chinese medicine preparation for treating blood viscosity symdrome and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03136116 CN1253171C (en) | 2003-05-15 | 2003-05-15 | Chinese medicine preparation for treating blood viscosity symdrome and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1473608A CN1473608A (en) | 2004-02-11 |
| CN1253171C true CN1253171C (en) | 2006-04-26 |
Family
ID=34154753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03136116 Expired - Fee Related CN1253171C (en) | 2003-05-15 | 2003-05-15 | Chinese medicine preparation for treating blood viscosity symdrome and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1253171C (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100443095C (en) * | 2004-09-24 | 2008-12-17 | 贵州益佰制药股份有限公司 | Compound formulation of breviscapine and asarum herb for treating cardiovascular and cerebrovascular diseases and its application |
-
2003
- 2003-05-15 CN CN 03136116 patent/CN1253171C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1473608A (en) | 2004-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102145128B (en) | Medicinal composition for preventing and treating cardiac and cerebral vascular diseases and preparation method thereof | |
| CN1112836A (en) | Meicinal prepn. "Kexianling" for curing epilepsy | |
| CN101474236A (en) | Ganoderma lucidum wall-broken spore powder capsule | |
| CN1304769A (en) | Blood-cleaning pill | |
| CN1698735A (en) | Medicine for treating psoriasis | |
| CN1124856C (en) | Pill for treating hemiplegia | |
| CN1253171C (en) | Chinese medicine preparation for treating blood viscosity symdrome and its preparing method | |
| CN1264549C (en) | Health-care food used for relaxing bowel, anti-senility and beautifying face | |
| CN1059559C (en) | Oral medicine and external-use medicine for curing osteonosus and processing method thereof | |
| CN101669995A (en) | Composite for treatment and health care of heart cerebrovascular diseases and preparation method thereof | |
| CN1053111C (en) | Chinese medical composite preparation with such functions as dispelling toxicity, detoxicating, recuperating, health preserving and face nursing | |
| CN101590097A (en) | The Chinese herbal medicine formula of a kind of blood pressure lowering, blood fat reducing and improvement sleep | |
| CN1850160A (en) | Qidantongmai Tablet, and its preparing process | |
| CN1424066A (en) | Chinese medical preparation for treating coronary disease and angina pectoris and preparation thereof | |
| CN1074928C (en) | Medicine for curing hemiplegia and its preparing process | |
| CN1212859C (en) | Acute cystourethritis treating medicine | |
| CN1053114C (en) | Medicine for curing bilestone and biliary calculus | |
| CN1151833C (en) | Capsule for reducing blood-lipid and preventing thrombosis | |
| CN1069531C (en) | Chinese medicine compositions and preparation for prevention and treatment of cerebrovascular atherosclerosis and cancer | |
| CN1292765C (en) | Pharmaceutical composition, its preparation process and usage | |
| CN1167458C (en) | Capsule (tablet) made from 5 pure Chinese medicinal plants for curing cardiovascular diseases, cerebrovascular disease and its preparation method | |
| CN1173365A (en) | Chinese medicinal preparation for curing rheumatism and rheumatoid disease and its prepn. method | |
| CN1269516C (en) | Medicine defatting and face nourishing | |
| CN1742834A (en) | Chinese medicine composition for treating diabets and preparing method | |
| CN1169543C (en) | Fat reducing health care product and its preparing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |